Publications
69
Citations
590
Est. group size
~1
Recurring co-author estimate
Active years
20
Publishing since 2007
Miriam Conces's work spans pediatric and adult oncology, including pathology of childhood tumors (such as neuroblastoma and granular cell tumors), long-term health outcomes in survivors of childhood cancer (like risk of second cancers, skin cancer, and leukemia), and clinical/genomic studies of adult cancers including neuroendocrine carcinomas and pancreatic cancer. The research combines pathology diagnostics, large survivor cohort studies, and early-phase clinical trials of novel cancer therapies.
Publication output has grown substantially over the past decade, rising from about 1 paper per year in 2017 to a sharp increase in 2025, with an average of roughly 8-9 papers per year over the last five years.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- Pathology of peripheral neuroblastic tumors
Diagnostic Pathology · 2026
- 1548 Benign, Atypical, or Malignant Granular Cell Tumor: Does Grading Correlate with Prognosis in Pediatric Patients? A 20-Year Institutional Experience
Laboratory Investigation · 2026
- Body Mass Index, Physical Activity, and Subsequent Neoplasm Risk Among Childhood Cancer Survivors
JAMA Oncology · 2025
- 36O First-in-human phase I study of a dual-conditionally active biologic (CAB) EpCAM x CD3 bispecific T-cell engager (TCE), BA3182, in patients with treatment refractory metastatic adenocarcinoma
ESMO Open · 2025
- Basal cell carcinoma risk prediction in survivors of childhood cancer
JNCI Journal of the National Cancer Institute · 2025
- Subsequent Meningiomas Among Survivors of Childhood Cancer
JAMA Network Open · 2025
- Temporal trends of subsequent central nervous system malignancies among survivors of childhood cancer
JNCI Journal of the National Cancer Institute · 2025
- NP-101 in combination with nivolumab and ipilimumab in metastatic extra-pulmonary neuroendocrine carcinomas (EP-NECs): a pilot study
Endocrine Abstracts · 2025
- Comparison of pulmonary versus extra-pulmonary small cell neuroendocrine carcinomas demonstrate distinct genomic alterations
Endocrine Abstracts · 2025
- Molecular landscape of extra-pulmonary small cell neuroendocrine carcinomas based on site of origin
Endocrine Abstracts · 2025
- Uncovering genomic differences between small and large cell extra-pulmonary neuroendocrine carcinomas
Endocrine Abstracts · 2025
- 486P Preliminary results from a first-in-human phase I study of a dual-conditionally binding EpCAM x CD3 bispecific T-cell engager, BA3182, in pts with treatment refractory metastatic adenocarcinoma
Annals of Oncology · 2025
- Safe Delivery of Ablative, Non-Adaptive Pancreas and Elective Nodal RT in Borderline Resectable and Locally Advanced Pancreatic Cancer
International Journal of Radiation Oncology*Biology*Physics · 2025
- 877eP Non-alcoholic fatty liver disease and risk of early-onset colorectal cancer in patients with type 2 diabetes
Annals of Oncology · 2025
- 1581P Results from a phase I dose escalation study of BA3182, a dual-conditionally active biologic (CAB) EpCAM x CD3 bispecific T cell engager in patients with treatment refractory metastatic adenocarcinoma
Annals of Oncology · 2025
- Pediatric and Developmental Pathology×6
- Endocrine Abstracts×4
- Nature Medicine×3
- Annals of Oncology×3
- Genes Chromosomes and Cancer×2
- Sandra Jones
Medicine · Indiana University
- Nicholas D. Yeager
Medicine · The Ohio State University
- Jennifer A. Belsky
Medicine · Indiana University
- A W Craft
Medicine · The Ohio State University
- Anthony Audino
Medicine · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile